Viewing Study NCT05913661

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:40 PM
Ignite Modification Date: 2026-02-08 @ 12:31 AM
Study NCT ID: NCT05913661
Status: UNKNOWN
Last Update Posted: 2023-06-22
First Post: 2023-06-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma View
None Intrahepatic Cholangiocarcinoma View
None Digestive System Neoplasms View
None PD-1 Inhibitor View
None First-line Treatment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None unresectable intrahepatic cholangiocarcinoma View
None metastatic intrahepatic cholangiocarcinoma View
None first-line treatment View
None Pemigatinib View
None PD-1 inhibitor View